His

His

His Liste de produits

Host Species
  • Mouse(10)
Conjugate
  • FA Labeled(3)
  • Acridinium ester Labeled(1)
  • AF488 Labeled(1)
  • Biotin-labeled(1)
  • Europium chelate Labeled(1)
  • HRP Labeled(1)
  • PE Labeled(1)
  • Unconjugated(1)
Reactive Species
  • -(4)
  • His tag (N‑terminal, C‑terminal, internal His‑tagged fusion proteins)(3)
  • Tag(2)
  • His tag (N-terminal, C-terminal and internal His-tagged fusion proteins)(1)
Applications
  • ELISA(3)
  • Flow(2)
  • MPCLIA(1)
  • WB(1)
MoleculeCat. No.Product NameHost SpeciesReactive SpeciesApplicationsSize&PriceAdd to Cart
His
HRP conjugated Monoclonal Anti-His Antibody, Human IgG1 (AY63)
Mouse
Tag
ELISAWB

$265.00

100ug
His
Monoclonal Anti-His Antibody, Human IgG1 (AY63)
Mouse
His tag (N-terminal, C-terminal and internal His-tagged fusion proteins)
ELISAWBSPR

$245.00

100ug
His
Monoclonal Anti-His Tag Antibody, Human IgG1 FA-Labeled (for TR-FRET)
Mouse
-
TR-FRET

$191.00

1000tests
His
Monoclonal Anti-His Tag Antibody, Mouse IgG1 FA-Labeled (for TR-FRET)
Mouse
-
TR-FRET

$191.00

1000tests
His
Monoclonal Anti-His Tag Antibody, Rabbit IgG FA-Labeled (for TR-FRET)
Mouse
-
TR-FRET

$191.00

1000tests
His
Monoclonal Anti-His Tag Antibody Europium chelate (for TR-FRET)
Mouse
-
TR-FRET

$191.00

1000tests
His
Alexa Fluor™ 488-Labeled Monoclonal Anti-His Antibody, Human IgG1 (55F8)
Mouse
His tag (N‑terminal, C‑terminal, internal His‑tagged fusion proteins)
Flow

$73.00

25tests
His
Biotinylated Anti-His Tag Antibody (AY63), Fab, Avitag™
Mouse
His tag (N‑terminal, C‑terminal, internal His‑tagged fusion proteins)
ELISA

$263.00

100ug
His
Monoclonal Anti-His Tag Antibody, Human IgG1-Acridinium ester (55F8)
Mouse
Tag
MPCLIA

$45.00

100ug
His
PE-Labeled Monoclonal Anti-His Antibody, Human IgG1 (55F8) (0.03% Proclin)
Mouse
His tag (N‑terminal, C‑terminal, internal His‑tagged fusion proteins)
Flow

$90.00

25tests
You Have Viewed 1-10 Of 10 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Praluzatamab ravtansineCX-2009Phase 2 ClinicalImmunogen Inc, Cytomx Therapeutics Inc
Solid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
Customer Reviews